Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a

Intuitive Surgical, Inc. (ISRG) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Intuitive Surgical, Inc. (ISRG) trades at a EV/Sales of 13.2×. Over the past ten years it has ranged from 6.6× (October 2015) to 25.5× (January 2025); the current reading is higher than 35% of that period. That is above the Medical Instruments & Supplies industry median of 2.9× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 19.5× (10.24%)
FY2024 21.7× 39.36%
FY2023 15.6× 7.30%
FY2022 14.5× (32.98%)
FY2021 21.7× 4.21%
FY2020 20.8× 43.29%
FY2019 14.5× 5.18%
FY2018 13.8× 8.39%
FY2017 12.7× 56.44%
FY2016 8.1× 3.76%

Quarterly newest first

Period EV/Sales Change
Jun 2026 12.3× (18.26%)
Mar 2026 15.0× (22.88%)
Dec 2025 19.5× 21.22%
Sep 2025 16.1× (22.39%)
42 more quarters

Against its own ten years

Low 6.6× High 25.5×
Ten-year median 14.7×
Current reading's percentile 29

EV/Sales against peers

Company EV/Sales
MDLN Medline Inc. compare 1.4×
BAX Baxter International Inc. compare 1.8×
SOLV Solventum Corporation compare 2.4×
BDX Becton, Dickinson and Company compare 2.9×
ALC Alcon compare 3.3×
RMD ResMed Inc. compare 6.0×
WST West Pharmaceutical Services, Inc. compare 8.1×
RGEN Repligen Corporation compare 12.3×
ISRG Intuitive Surgical, Inc. 13.2×
Medical Instruments & Supplies industry median 2.9×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ISRG